glp 1 rezeptor antagonist Frontiers GLP-1-Rezeptoragonisten Kompakt | Gelbe Liste
Description
Eur Neuropsychopharmacol
10.1136/bjophthalmol-2016-308894
Conclusions/interpretation Our findings do not support an increased risk of SIS when taking GLP-1RA in individuals with type 2 diabetes and obesity
The GLP-1 effect is also influencing consumer behavior and product choices in weight management
Some patients take it in the morning or evening
Gilbert MP, Pratley RE
